Norbrook Meloxicam 1.5mg/ml Oral Suspension for Dogs

Ország: Egyesült Királyság

Nyelv: angol

Forrás: VMD (Veterinary Medicines Directorate)

Vedd Meg Most

Termékjellemzők Termékjellemzők (SPC)
02-06-2023

Aktív összetevők:

Meloxicam

Beszerezhető a:

Norbrook Laboratories Limited

ATC-kód:

QM01AC06

INN (nemzetközi neve):

Meloxicam

Gyógyszerészeti forma:

Oral suspension

Recept típusa:

POM-V - Prescription Only Medicine – Veterinarian

Terápiás csoport:

Dogs

Terápiás terület:

Anti Inflammatory NSAID

Engedélyezési státusz:

Authorized

Engedély dátuma:

2016-02-11

Termékjellemzők

                                Revised: December 2022
AN: 02473/2022
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Norbrook Meloxicam 1.5mg/ml Oral Suspension for Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Meloxicam
1.5 mg
EXCIPIENTS:
Sodium Benzoate
1.5 mg
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Oral suspension
Pale yellow suspension.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Alleviation of inflammation and pain in both acute and chronic
musculo-skeletal
disorders in dogs.
4.3
CONTRAINDICATIONS
Do not use in pregnant or lactating animals.
Do not use in animals suffering from gastrointestinal disorders such
as irritation and
haemorrhage, impaired hepatic, cardiac or renal function and
haemorrhagic
disorders.
Do not use in case of hypersensitivity to the active substance or to
any of the
excipients.
Do no use in dogs less than 6 weeks of age.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: December 2022
AN: 02473/2022
Page 2 of 6
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
If adverse reactions occur, treatment should be discontinued and the
advice of a
veterinarian should be sought.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as
there is a
potential risk of renal toxicity.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
People with known hypersensitivity to non-steroidal anti-inflammatory
drugs
(NSAIDs) should avoid contact with the veterinary medicinal product.
In case of accidental ingestion, seek medical advice immediately and
show the
package leaflet or the label to the physician.
Wash any splashes from skin immediately with water.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Typical adverse reactions of NSAIDs such as loss of appetite,
vomiting, diarrhoea,
faecal occult blood, apathy and renal failure have been reported very
rarely in
spontane
                                
                                Olvassa el a teljes dokumentumot
                                
                            

A termékkel kapcsolatos riasztások keresése